Literature DB >> 24774116

Preoperative levosimendan for right ventricular dysfunction before heart valve replacement surgery.

José Luis Guerrero Orriach1, Isabel Navarro Arce2, Pablo Iglesias2, Manuel Galán Ortega2, Manuel Rubio Navarro2, José Cruz Mañas2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24774116     DOI： 10.1016/j.rec.2013.05.015

Source DB:  PubMed          Journal:  Rev Esp Cardiol (Engl Ed)        ISSN： 1885-5857


× No keyword cloud information.
  4 in total

1.  Assessing the effect of preoperative levosimendan on renal function in patients with right ventricular dysfunction.

Authors:  Jose L Guerrero Orriach; M Galán Ortega; A Ramírez Fernandez; D Ariza Villanueva; A Florez Vela; I Moreno Cortés; M Rubio Navarro; J Cruz Mañas
Journal:  J Clin Monit Comput       Date:  2016-01-13       Impact factor: 2.502

2.  Preservation of renal function in cardiac surgery patients with low cardiac output syndrome: levosimendan vs beta agonists.

Authors:  Jose Luis Guerrero Orriach; I Navarro Arce; P Hernandez Rodriguez; A Raigón Ponferrada; A Malo Manso; M Ramirez Aliaga; A Ramirez Fernandez; J J Escalona Belmonte; I Bellido Estevez; A Gomez Luque; R Barrera Serrano; C S Toledo Medina; M Rubio Navarro; J Cruz Mañas
Journal:  BMC Anesthesiol       Date:  2019-11-17       Impact factor: 2.217

3.  Levosimendan reduces segmental pulmonary vascular resistance in isolated perfused rat lungs and relaxes human pulmonary vessels.

Authors:  Annette Dorothea Rieg; Said Suleiman; Nina Andrea Bünting; Eva Verjans; Jan Spillner; Heike Schnöring; Sebastian Kalverkamp; Thomas Schröder; Saskia von Stillfried; Till Braunschweig; Gereon Schälte; Stefan Uhlig; Christian Martin
Journal:  PLoS One       Date:  2020-05-18       Impact factor: 3.240

4.  Cardiac, renal, and neurological benefits of preoperative levosimendan administration in patients with right ventricular dysfunction and pulmonary hypertension undergoing cardiac surgery: evaluation with two biomarkers neutrophil gelatinase-associated lipocalin and neuronal enolase.

Authors:  José Luis Guerrero-Orriach; Daniel Ariza-Villanueva; Ana Florez-Vela; Lourdes Garrido-Sánchez; María Isabel Moreno-Cortés; Manuel Galán-Ortega; Alicia Ramírez-Fernández; Juan Alcaide Torres; Concepción Santiago Fernandez; Isabel Navarro Arce; José María Melero-Tejedor; Manuel Rubio-Navarro; José Cruz-Mañas
Journal:  Ther Clin Risk Manag       Date:  2016-04-21       Impact factor: 2.423
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.